Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Most of us believe we "hit" statistical significan

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154721
(Total Views: 845)
Posted On: 02/24/2021 9:18:11 AM
Avatar
Posted By: TechGuru
Most of us believe we "hit" statistical significance in the PE .

483814241_ForBorel.jpg

In average, we believe that SOC had a 34.2 % of deaths (44.8) and VX had 16.4% (42.9) with a death improvement of 52.2%.

This would produce a p-value of 0.0000809 (yes, 4 zeroes). Not delving too much into this. BorelFields already posted a very complete analysis of this data.

OK, imho we are being a bit optimistic. But, please take any number you like for SOC deaths. Say 30%, please do remember that midway our trial we had a 23.1% overall death rate (45/195) at a time that most trials were reporting SOC deaths exceeding 30%)

With this (SOC=30%) we have a 2-tailed p-value of 0.01377 (38.5% death reduction)

So, do we have GRANTED that we meet statistical significance ??? No. There are combinations of events that can result in us not getting there. For example, in the second part of out trial the SOC survival improved dramatically AND VX decreased idem (please do remember that the overall death rate at the end of the trial is very similar to that of the first part).

Or, in the second part of trial, the SOC got mostly severe and we got mostly critical ... and opposite in the first cohort.

Or, VX worked in the first part of the trial and by some "act of the devil" did not work as effectively in the second part ...., while the good doctors were recovering SOC patients at a much better rate.

But ... but ... you get my point ???. Entienden ???

And yes, we longs are a very optimistic bunch ... but we are not delusional.

Only COD afflicts us




(27)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us